Condition: Cardiovascular Disease (CVD) · Cardiovascular Risk Factor · Vascular Stiffness · Sponsor: St. Boniface Hospital
The main objective of this study is to test the ability of novel cardiovascular disease (CVD) prognostic tools to identify women at risk for future CVD. We plan to establish a cardiovascular health screening program at the St. Boniface Hospital and to test the efficacy of these tests for predicting adverse cardiovascular outcomes amongst a cohort of 1000 Manitoban women aged 55 years and older in the 5-year period after screening. A second purpose of this project is to identify novel CVD biomarkers that may indicate a person is at risk for cardiovascular disease. Therefore, we plan to ask participants for permission to collect and store a sample of both their blood and stool for future research.
This description comes directly from the study's public registry record.
Todd Duhamel, PhD · 204-235-3589 · tduhamel@sbrc.ca
Kevin Boreskie, MSc · 204-480-1815 · kboreskie@sbrc.ca
Always discuss trial participation with your own doctor first.
| St. Boniface Hospital Albrechtsen Research Centre | Winnipeg, Manitoba, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03938155